| Protocal Title |
Protocol Number |
Control Number |
Principal Investigator |
| Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma |
CALGB-80101 |
FH03-071 |
Dr. Allen Terzian
|
|
| A Phase III Randomized Double-Blind Study of Adjuvant STI1571 (Gleevec) versus Placebo in Patients Following the Resection
of Primary Gastrointestinal Stromal Tumor (GIST)
|
ACOSOG Z9001 |
FH04-091 |
Dr. Allen Terzian
|
|
| A Randomized Phase III Trial of Gemcitabine Plus Bevacizumab (NSC #704865 IND #7921) versus Gemcitabine Plus Placebo in Patients
with Advanced Pancreatic Cancer
|
CALGB 80303 |
FH05-101 |
Dr. Allen Terzian
|
|
| A Phase III Clinical Trial Comparing Infusion 5-Flourourcil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks
with Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients with Resected Stages II and III Carcinoma
of the Colon
|
NSABP C-08 |
FH05-113 |
Dr. Allen Terzian
|
|
| Randomized Phase II Trial of Neoadjuvant Combined Modality Therapy for Locally Advanced Rectal Cancer |
RTOG 0247 |
FH05-115 |
Dr. Shari Rudoler
|
|
| A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab
in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular
Markers (Revised Protocol Addendum #5 dated January 11, 2006; Revised Consent dated 3/06)
|
E5202 |
FH05-122 |
Dr. Allen Terzian
|
|
